Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPembroke Vct Regulatory News (PEMB)

Share Price Information for Pembroke Vct (PEMB)

Share Price is delayed by 15 minutes
Get Live Data
92.00    0.00 (0.00%)
Bid:
90.00
Ask:
94.00
Spread: 4.00 (4.444%)
Market Cap: £269.20m
PEMB Live PriceLast checked at - London Stock Exchange

Intraday Pembroke Vct Share Chart

Directorate Change

30 May 2024 14:55

RNS Number : 5154Q
Pembroke VCT PLC
30 May 2024
 

Pembroke VCT plc (the "Company")

 

 

Directorate Change

 

The Company is pleased to announce that Christopher Allner has been appointed as a non-executive director of the Company with effect from 1 June 2024.

 

Louise Wolfson, the chair of the Company's Remuneration & Nomination Committee commented: "We are delighted that Chris has agreed to join us and welcome him to an already talented board. His extensive knowledge and experience in the VCT industry will be of great benefit to us. We are confident that his contribution will be of substantial value as we continue to grow the Company." 

 

Christopher is a non-executive director of Thames Ventures VCT 1 plc and of Thames Ventures VCT 2 plc. He is also a partner in Downing LLP and chairs its Investment Committee. There is no further information to be disclosed pursuant to Listing Rule 9.6.13R in relation to this appointment.

 

 

30 May 2024

 

 

For further information, please contact:

Andrew Wolfson / Chris Lewis

Pembroke Investment Managers LLP (Manager)

+44 20 7766 6900

 

Robin Smeaton

The City Partnership (UK) Limited (Company Secretary)

enquiries@city.uk.com

 

Keith Lassman

Howard Kennedy Corporate Services LLP

keith.lassman@howardkennedy.com 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEVESIIVIS
Date   Source Headline
7th Dec 20233:36 pmRNSIssue of Equity
1st Dec 202311:42 amRNSTotal Voting Rights
28th Nov 20231:48 pmRNSIssue of Equity
24th Nov 202311:48 amRNSHalf-yearly Report
6th Nov 202312:45 pmRNSTotal Voting Rights
25th Oct 20234:18 pmRNSIssue of Equity
19th Oct 20236:32 pmRNSDirector/PDMR Shareholding
17th Oct 202310:41 amRNSPurchase of Own Securities
2nd Oct 20232:15 pmRNSTotal Voting Rights
2nd Oct 20231:36 pmRNSIssue of Equity
28th Sep 202312:48 pmRNSResult of AGM
5th Sep 202310:46 amRNSPublication of Prospectus
10th Aug 20231:32 pmRNSNet Asset Value(s)
10th Aug 20231:28 pmRNSDividend Declaration
2nd Aug 20233:44 pmRNSTotal Voting Rights
29th Jun 20235:06 pmRNSAnnual Report & Financial Statements
21st Jun 202310:31 amRNSIntention to Launch an Offer for Subscription
5th Jun 202311:27 amRNSIssue of Equity
2nd May 20239:26 amRNSIssue of Equity
24th Apr 20233:00 pmRNSNotice of Close of Offer
17th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20233:06 pmRNSIssue of Equity
6th Apr 20237:00 amRNSIssue of Equity
31st Mar 202311:54 amRNSIssue of Equity
28th Feb 20231:12 pmRNSIssue of Equity
6th Feb 20237:00 amRNSDividend Declaration & NAV per Share
1st Feb 202310:06 amRNSIssue of Equity
15th Dec 202211:42 amRNSIssue of Equity
16th Nov 202210:50 amRNSHalf-year Report
28th Oct 202210:27 amRNSIssue of Equity
5th Oct 20224:14 pmRNSIssue of Equity
29th Sep 20229:30 amRNSResult of AGM
8th Sep 202210:42 amRNSPublication of a Prospectus
11th Aug 20227:00 amRNSNet Asset Value per B Ordinary Share
4th Aug 20227:00 amRNSIssue of Equity
28th Jun 20226:23 pmRNSIntention to Launch an Offer for Subscription
28th Jun 20226:15 pmRNSAnnual Financial Report
13th May 20222:03 pmRNSIssue of Equity
9th May 202212:39 pmRNSClose of Offer to Further Applications
6th May 20225:56 pmRNSTotal Voting Rights
13th Apr 202211:03 amRNSIssue of Equity
8th Apr 20227:53 amRNSDirector/PDMR Shareholding
6th Apr 202210:28 amRNSIssue of Equity
1st Apr 202211:56 amRNSTotal Voting Rights
31st Mar 20225:44 pmRNSIssue of Equity
25th Mar 20228:51 amRNSOffer for subscription: over-allotment facility
23rd Mar 20227:00 amRNSInvestment Exit
7th Mar 202212:41 pmRNSIssue of Equity
10th Feb 202210:38 amRNSNet Asset Value per Share
2nd Feb 202210:18 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.